Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials

【Abstract】 Objective: The effect of tranexamic acid (TA) on patients receiving total knee arthroplasty (TKA) has been reported in many small clinical trials. But single trials are not sufficient enough to clarify the effectiveness and safety of TA. So, we carried out a meta-analysis of rando...

Full description

Bibliographic Details
Main Authors: FU De-jie, CHEN Cheng, GUO Lin, YANG Liu
Format: Article
Language:English
Published: Elsevier 2013-04-01
Series:Chinese Journal of Traumatology
Online Access:http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/385
id doaj-5304ec0585064e30a327075d055953f6
record_format Article
spelling doaj-5304ec0585064e30a327075d055953f62020-11-24T21:05:36ZengElsevierChinese Journal of Traumatology1008-12752013-04-011626776208Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trialsFU De-jieCHEN ChengGUO LinYANG Liu【Abstract】 Objective: The effect of tranexamic acid (TA) on patients receiving total knee arthroplasty (TKA) has been reported in many small clinical trials. But single trials are not sufficient enough to clarify the effectiveness and safety of TA. So, we carried out a meta-analysis of randomized controlled trials to investigate the efficacy and safety of the intravenous use of TA in TKA. Methods: Literatures were retrieved in Cochrane Library, OVID, PubMed, EMBASE, CNKI and Wanfang Data. All the related literatures were checked by two independent investigators and only the high quality randomized con-trolled trials were enrolled. Relevant data were analyzed using RevMan 5.1 to compare the difference of blood loss, transfusion and complications between TA group and con-trol group. Results: There were 353 related literatures and only 22 randomized controlled trials met the inclusion criteria. The use of TA in TKA significantly reduced total blood loss by a mean of 435.41 ml (95% CI 300.62-570.21, P<0.01), post-operative blood loss by a mean of 406.69 ml (95% CI 333.16-480.22, P<0.01). TA also significantly lowered the transfu-sion rate (risk difference 0.30, 95% CI 0.21-0.39, P<0.01) and transfusion volume (mean difference 0.95 unit, 95% CI 0.53-1.37, P<0.01). The risks between TA group and control group in developing deep vein thrombosis and pulmonary embo-lism were not statistically significant. Conclusion: TA is beneficial for patients undergoing TKA, which can significantly reduce total blood loss, post-operative blood loss, transfusion rate, and transfusion volume. Meanwhile TA is recommended to reduce deep vein thrombosis and pulmonary embolism following TKA. Key words: Tranexamic acid; Arthroplasty; Knee; Blood loss, surgical; Meta-analysishttp://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/385
collection DOAJ
language English
format Article
sources DOAJ
author FU De-jie
CHEN Cheng
GUO Lin
YANG Liu
spellingShingle FU De-jie
CHEN Cheng
GUO Lin
YANG Liu
Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
Chinese Journal of Traumatology
author_facet FU De-jie
CHEN Cheng
GUO Lin
YANG Liu
author_sort FU De-jie
title Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
title_short Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
title_full Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
title_fullStr Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
title_full_unstemmed Use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
title_sort use of intravenous tranexamic acid in total knee arthroplasty: a meta-analysis of randomized controlled trials
publisher Elsevier
series Chinese Journal of Traumatology
issn 1008-1275
publishDate 2013-04-01
description 【Abstract】 Objective: The effect of tranexamic acid (TA) on patients receiving total knee arthroplasty (TKA) has been reported in many small clinical trials. But single trials are not sufficient enough to clarify the effectiveness and safety of TA. So, we carried out a meta-analysis of randomized controlled trials to investigate the efficacy and safety of the intravenous use of TA in TKA. Methods: Literatures were retrieved in Cochrane Library, OVID, PubMed, EMBASE, CNKI and Wanfang Data. All the related literatures were checked by two independent investigators and only the high quality randomized con-trolled trials were enrolled. Relevant data were analyzed using RevMan 5.1 to compare the difference of blood loss, transfusion and complications between TA group and con-trol group. Results: There were 353 related literatures and only 22 randomized controlled trials met the inclusion criteria. The use of TA in TKA significantly reduced total blood loss by a mean of 435.41 ml (95% CI 300.62-570.21, P<0.01), post-operative blood loss by a mean of 406.69 ml (95% CI 333.16-480.22, P<0.01). TA also significantly lowered the transfu-sion rate (risk difference 0.30, 95% CI 0.21-0.39, P<0.01) and transfusion volume (mean difference 0.95 unit, 95% CI 0.53-1.37, P<0.01). The risks between TA group and control group in developing deep vein thrombosis and pulmonary embo-lism were not statistically significant. Conclusion: TA is beneficial for patients undergoing TKA, which can significantly reduce total blood loss, post-operative blood loss, transfusion rate, and transfusion volume. Meanwhile TA is recommended to reduce deep vein thrombosis and pulmonary embolism following TKA. Key words: Tranexamic acid; Arthroplasty; Knee; Blood loss, surgical; Meta-analysis
url http://www.cjtrauma.com/apps/ojs/index.php/cjt/article/view/385
work_keys_str_mv AT fudejie useofintravenoustranexamicacidintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT chencheng useofintravenoustranexamicacidintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT guolin useofintravenoustranexamicacidintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
AT yangliu useofintravenoustranexamicacidintotalkneearthroplastyametaanalysisofrandomizedcontrolledtrials
_version_ 1716768198112575488